James T. Rybicki

James T. Rybicki, Chairman, has a strong sales and marketing background. After five years with Johnson & Johnson and Bausch & Lomb, he joined Hydrocurve, which in 1980 was sold to Revlon for $30 million. Mr. Rybicki then joined IOPTEX Inc., where in 1986 he became one of four principals as a result of a leveraged buyout with Merrill Lynch and Johnston & Associates. IOPTEX was sold to Smith & Nephew, Inc. in 1989 for $236 million. In 1992, he became a private investor in microcap medical device companies with a specific emphasis on orthopedics and ophthalmology.